↓ Skip to main content

Tigecycline for the Treatment of Severe and Severe Complicated Clostridium difficile Infection

Overview of attention for article published in Infectious Diseases and Therapy, December 2014
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (71st percentile)
  • High Attention Score compared to outputs of the same age and source (99th percentile)

Mentioned by

twitter
7 X users

Citations

dimensions_citation
35 Dimensions

Readers on

mendeley
33 Mendeley
Title
Tigecycline for the Treatment of Severe and Severe Complicated Clostridium difficile Infection
Published in
Infectious Diseases and Therapy, December 2014
DOI 10.1007/s40121-014-0050-x
Pubmed ID
Authors

Nicholas S. Britt, Molly E. Steed, Emily M. Potter, Lisa A. Clough

Abstract

Clostridium difficile infection (CDI) is a common cause of nosocomial diarrhea. Metronidazole and vancomycin are the primary treatment options for CDI, but increasing rates of antimicrobial resistance and severe, refractory disease have prompted the need for alternative agents. Tigecycline has previously demonstrated favorable in vitro activity against C. difficile isolates, but clinical data on its use in the treatment of CDI are severely lacking. The objective of this study was to describe our experience using tigecycline in the treatment of severe and severe complicated CDI.

X Demographics

X Demographics

The data shown below were collected from the profiles of 7 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 33 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Spain 1 3%
Unknown 32 97%

Demographic breakdown

Readers by professional status Count As %
Student > Master 7 21%
Professor > Associate Professor 6 18%
Other 4 12%
Student > Ph. D. Student 4 12%
Researcher 3 9%
Other 5 15%
Unknown 4 12%
Readers by discipline Count As %
Medicine and Dentistry 13 39%
Immunology and Microbiology 4 12%
Nursing and Health Professions 3 9%
Pharmacology, Toxicology and Pharmaceutical Science 2 6%
Biochemistry, Genetics and Molecular Biology 2 6%
Other 3 9%
Unknown 6 18%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 15 May 2018.
All research outputs
#7,270,153
of 23,133,982 outputs
Outputs from Infectious Diseases and Therapy
#263
of 702 outputs
Outputs of similar age
#102,407
of 362,792 outputs
Outputs of similar age from Infectious Diseases and Therapy
#1
of 10 outputs
Altmetric has tracked 23,133,982 research outputs across all sources so far. This one has received more attention than most of these and is in the 68th percentile.
So far Altmetric has tracked 702 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 12.1. This one has gotten more attention than average, scoring higher than 61% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 362,792 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 71% of its contemporaries.
We're also able to compare this research output to 10 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them